Global RSV Diagnostics
Market Report
2024
RSV Diagnostics Market Report 2024 (Global Edition)
RSV diagnostic market was valued at USD 946.08 million in 2022 and will reach USD 2087.76 million by 2030, registering a CAGR of 10.4% for the forecast period 2023-2030.
The base year for the calculation is 2023 and 2019 to 2023 will be historical period. The year 2024 will be estimated one while the forecasted data will be from year 2025 to 2031. When we deliver the report that time we updated report data till the purchase date.
PDF Access: Password protected PDF file, Excel File Access: Quantitative data, PPT Report Access: For the presentation purpose, Cloud Access: Secure Company Account Access.
| Share your contact details to receive free updated sample copy/pages of the recently published edition of RSV Diagnostics Market Report 2024.
Global RSV Diagnostics Market Report 2024 Market Size Split by Product (Instruments, Kits and Reagents, Others), by End User (Hospitals and Clinics, Clinical Laboratories, Homecare, Others), by Method...
The global respiratory syncytial virus (RSV) diagnostic market was valued at USD 946.08 million in 2022 and will reach USD 2087.76 million by 2030, registering a CAGR of 10.4% for the forecast period 2023-2030.
| Base Year | 2023 |
| Historical Data Time Period | 2019-2023 |
| Forecast Period | 2024-2031 |
| Global RSV Diagnostics Market Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 10.4% |
| Market Split by Product |
|
| Market Split by End User |
|
| Market Split by Method |
|
| List of Competitors |
|
| Regional Analysis |
|
Country Analysis |
|
Key Qualitative Information Covered |
|
Report scope is customizable as we have a huge database of RSV Diagnostics industry. We can deliver an exclusive report Edition/Consultation as per your data requirements. Request for your Free Sample Pages.
RSV Diagnostics Market is Segmented as below. Particular segment of your interest can be provided without any additional cost. Download the Sample Pages!
RSV Diagnostics Market Report Description
Respiratory syncytial virus (RSV) causes infections of the lungs and respiratory tract that usually cause mild, cold-like symptoms. Most people recover in a week or two, but RSV can be serious, especially for infants and older adults. In adults and older, healthy children, RSV symptoms are mild and typically mimic the common cold. Self-care measures are usually all that has needed to relieve any discomfort. RSV can cause severe infection in some people, including babies 12 months and younger (infants), especially premature infants, older adults, people with heart and lung disease, or anyone with a weak immune system (immunocompromised). The respiratory syncytial virus enters the body through the eyes, nose, or mouth. It spreads easily through the air on infected respiratory droplets. You or your child can become infected if someone with RSV coughs or sneezes near you.
RSV is a disease that influences millions of children each year. Supportive care including nutrition, hydration, clearing of nasal secretions, and oxygen, if needed, remains the mainstay therapy for patients. Good handwashing techniques and contact isolation should be conducted to prevent RSV transmission.
Direct fluorescent antibody (DFA), Rapid antigen detection tests (RADTs) and polymerase chain reaction (PCR) testing, and culture can all be used to find respiratory syncytial virus (RSV). If RSV is the primary concern, DFA testing or RADTs may be used, especially in newborns and kids.
Market dynamics of the respiratory syncytial virus (RSV) diagnostic market:
Driving factors:
- Increasing prevalence of respiratory syncytial virus (RSV) disorder:
The respiratory syncytial virus (RSV), which affects the nose, throat, lungs, and breathing passages, is a common respiratory virus. RSV is communicated by touching surfaces that have been exposed to the virus and then contacting your eyes, nose, or mouth, or by inhaling respiratory droplets (coughing, sneezing, or kissing) from an infected person. RSV is frequently transmitted to kids outside of the house, at school, or in childcare facilities. They can then spread the illness to other family members.
Rapid antigen detection tests (RADTs), direct fluorescent antibody (DFA) and polymerase chain reaction (PCR) testing, and culture can all be used to find respiratory syncytial virus (RSV). If RSV is the primary concern, DFA tests or RADTs may be used, especially in infants and children.
One of two tests is commonly used to diagnose RSV infections:
Rapid RSV antigen testing is the most common RSV test. A sample of mucus from your nose is tested for the detection of certain RSV antigens, which are proteins from the virus. When exposed to RSV antigens, your immune system begins to combat the viral infection. Fast antigen tests can yield results in a few hours or less.
The genetic material from the RSV virus is sought after using molecular assays termed RT-PCRs (polymerase chain reaction). Fewer viruses can be detected by these tests than by antigen assays. Because adults and elderly people typically have less virus in their sinuses than babies and younger children, RT-PCR assays may be used to diagnose them. Usually, samples are sent to a laboratory for examination. A genetic test called a respiratory pathogens panel could occasionally be requested by your doctor. This examination screens for RSV as well as additional respiratory viral and bacterial infections. Therefore, the demand and use of respiratory syncytial virus (RSV) diagnostics in RSV infection can boost the market.
- New Advances in the Diagnosis, Prevention, and Treatment of Respiratory Syncytial Virus (RSV):
One of the key market drivers is the development of respiratory syncytial virus (RSV) diagnostics. The development of current RSV detection technologies, such as western blot, enzyme-linked immunosorbent assay (ELISA), direct immunofluorescence, and real-time polymerase chain reaction (PCR), will likely be made easier by the development of advanced techniques, including bio- and nanotechnology. RSV diagnostics market expansion is also anticipated to be fueled by quick FDA approvals, public and private funding of the healthcare system, and significant investments in research and development (R&D) programs during the projected year.
The launch of new products and the increasing interest of competitors in this industry is expected to boost the growth of respiratory syncytial virus (RSV) diagnostics. For instance, in May 2023 The Panther Fusion® SARS-CoV-2/Flu A/B/RSV assay from Hologic Inc. received 510(k) clearance from the FDA. It is a molecular diagnostic test that distinguishes between four common respiratory viruses, including RSV, influenza A, influenza B, and SARS-CoV-2.
Restraining factors:
- The high cost and lack of skilled professionals:
A significant limiting factor for the growth of the global RSV diagnostics market is the high cost of the diagnostic. The field has experienced fast technical advancement, which has also contributed to a specialist talent gap. The lack of qualified professionals severely hinders both handling of instruments and completing procedures.
The high cost of technologically advanced diagnostic devices is a major restraining factor for market growth. The expensive cost of RSV diagnostics also tempts customers away from the new and improved system and towards secondhand systems, which negatively influences their bottom lines.
Impact of COVID- 19 pandemic on the respiratory syncytial virus (RSV) diagnostic market:
Clinicians and researchers have recognized parallels and differences between RSV and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) during the era of the coronavirus disease 2019 (COVID-19). Public health and social measures (PHSMs), which include personal protective measures including mask use, hand cleanliness, social seclusion, environmental measures, and surveillance and response measures, have been widely implemented throughout the COVID-19 era. PHSMs are crucial in the fight against SARS-CoV-2 transmission. Other respiratory viral illnesses have also been greatly impacted by the introduced PHSMs. Numerous studies have revealed a striking decline in RSV and another common respiratory pathogen occurrence throughout the COVID-19 era.
The COVID-19 pandemic's global expansion has raised demand for quick testing kits. Numerous businesses are giving their RSV diagnosis test kits for testing COVID-19 since the novel coronavirus affects the respiratory system. For instance, Mesa Biotech's Accula gadget, which produces findings for COVID-19 in around 30 minutes, recently received approval from the US FDA. The market for RSV diagnostics is anticipated to expand as a result of the usage of such RSV diagnostic tools for COVID-19 testing.
We have various report editions of RSV Diagnostics Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.
RSV Diagnostics Market Insights Video
Recent developments:
May 2023
- Hologic Announced FDA Clearance of Panther Fusion SARS-CoV-2/Flu A/B/RSV Assay
The Panther Fusion® SARS-CoV-2/Flu A/B/RSV assay from Hologic Inc. has received 510(k) clearance from the U.S. Food and Drug Administration (FDA). This assay is a molecular diagnostic test that distinguishes between the four most common respiratory viruses, including the respiratory syncytial virus (RSV), influenza A, influenza B, and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
May 2023
- US FDA approved GSK’s Arexvy, the world’s first respiratory syncytial virus (RSV) vaccine for older adults
The lower respiratory tract disease (LRTD) brought on by the respiratory syncytial virus (RSV) in people 60 years of age and older has been approved by the US Food and Drug Administration (FDA), according to a GSK plc announcement. This is the first RSV vaccination for senior citizens to receive worldwide approval.
October 2022
- Roche announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the cobas SARS-CoV-2 Qualitative PCR test for use on the fully automated cobas 6800 and cobas 8800 Systems.
According to a statement from Roche, the FDA has approved the cobas SARS-CoV-2 Qualitative PCR test for use on the fully automated cobas 6800 and cobas 8800 Systems. This stand-alone test is intended for the qualitative detection of SARS-CoV-2, the virus that causes COVID-19 disease, in nasal and nasopharyngeal samples from COVID-19-suspected symptomatic patients as assessed by their healthcare practitioner.
June 2022
- BD Launched Combination Test for COVID-19, Influenza A/B, and Respiratory Syncytial Virus
The BD MAXTM Respiratory Viral Panel (RVP), a new molecular diagnostic combination test for SARS-CoV-2, Influenza A + B, and Respiratory Syncytial Virus (RSV), has received CE marking by the IVD directive 98/79/EC, according to BD (Becton, Dickinson, and Company), a major global provider of medical technology. If a patient has COVID-19, the flu, or RSV, the test uses a single nose swab or a single nasopharyngeal swab sample to make the diagnosis. It helps reduce the need for numerous tests or doctor visits and enables professionals to immediately implement the best action.
November 2021
- QIAGEN announced the launch and CE-marking of the QIAstat-Dx Respiratory 4 Plex Flu A-B/RSV/SARS-CoV-2 test for the QIAstat-Dx system
The QIAstat-Dx Respiratory 4 Plex Flu A-B/RSV/SARS-CoV-2 test for the QIAstat-Dx system has been launched and CE-marked by QIAGEN. It can be used to quickly determine whether patients have seasonal respiratory illnesses or SARS-CoV-2. In the COVID-19 pandemic, the novel Respiratory 4 Plex Flu A-B/RSV/SARS-CoV-2 test from QIAGEN is a potent diagnostic tool, particularly during influenza-like illness (ILI) or "flu" seasons. It uses the simple-to-use QIAstat-Dx modular cartridge-based system to provide quick results with no further sample preparation.
Top Companies Market Share in RSV Diagnostics Industry: (In no particular order of Rank)
- Abbott
- BIOMERIEUX (France)
- Becton
- Dickinson and Company
- Merck KGaA
- DiaSorin Molecular LLC
- F. Hoffman La. Roche Ltd
- Danaher
- bioMérieux SA
- Thermo Fisher Scientific Inc.
- Luminex Corporation
- Quest Diagnostics Incorporated
- BioCartis
- Hologic
- Inc.
- Fast Track Diagnostics Luxembourg S.à r.l.
- Beckman Coulter Inc.
- Ortho-Clinical Diagnostics
- Bio-Rad Laboratories Inc. Quidel Corporation
- DiaSorin S.p.A.
- Confidential Data
- Access The Paid Version
- Data Hidden
If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.
North America held the largest revenue market share over the other regions in the global respiratory syncytial virus (RSV) diagnostic market:
The rising incidence of respiratory syncytial virus infections in the region, expanding R&D activities, rising investments, and support for government initiatives and key market players' initiatives are the main factors propelling the growth of the North American respiratory syncytial virus (RSV) market. Due to their excellent accuracy, sensitivity, and specificity, chromatographic immunoassays and molecular diagnostics are the two main products used in the region and their demand is rapidly rising. Growing numbers of strategic alliances between pharmaceutical industry leaders and in vitro diagnostic manufacturing companies are expected to make this a profitable market by highlighting the enormous potential.
Accuracy and speedy results from improved diagnostic tests are anticipated to hasten market expansion in the area. Europe is a prosperous continent as well. The market size in developed nations in Europe and North America is projected to increase due to the significant healthcare burden of respiratory syncytial virus infection in these nations.
The current report Scope analyzes RSV Diagnostics Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com
- North America (United States, Canada, Mexico)
- Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium)
- Asia-Pacific (China, Japan, Korea, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest of APAC)
- South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
- Middle East and Africa (Saudi Arabia, Turkey, Nigeria, UAE, Egypt, South Africa, GCC Countries, Rest of MEA)
RSV Diagnostics Market Share (%) by Region (2019-2031)
The above graph is for illustrative purposes only. To learn more about geographical trends request the free sample pages. Contact US!
RSV Diagnostics Market Analysis
Global RSV Diagnostics Market Report 2024 Edition talks about crucial market insights with the help of segments and sub-segments analysis. In this section, we reveal an in-depth analysis of the key factors influencing RSV Diagnostics Industry growth. RSV Diagnostics market has been segmented with the help of its Product, End User Method, and others. RSV Diagnostics market analysis helps to understand key industry segments, and their global, regional, and country-level insights. Furthermore, this analysis also provides information pertaining to segments that are going to be most lucrative in the near future and their expected growth rate and future market opportunities. The report also provides detailed insights into factors responsible for the positive or negative growth of each industry segment.
By this method, molecular diagnostics accounted largest revenue share in the global medical device market.
By method segments market into immunoassays, molecular diagnostics, flow cytometry, rapid antigen detection tests, and chromatography, in which molecular diagnostics held the largest share of the market.
Polymerase chain reaction (PCR) molecular diagnostics examine for genetic material from the RSV virus in your sample. Compared to antigen tests, these types of tests can detect smaller viral concentrations. Therefore, RT-PCR testing may be utilized on adults and older children as they often have lower levels of the virus in their noses than babies and younger children do. Typically, samples are sent to a lab for analysis. Your doctor may occasionally request a molecular test known as a respiratory pathogens panel. This test simultaneously examines RSV, other respiratory viruses, and bacterial diseases. Increasing adoption of molecular diagnostics to boost the respiratory syncytial virus diagnostics market, Owing to the Increasing burden of infectious diseases.
- Instruments
- Kits and Reagents
- Others
RSV Diagnostics Market Share (%) by Product in 2019-2031
The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of RSV Diagnostics Industry. Request a Free Sample PDF!
By End Users, hospitals and clinics dominated the worldwide medical devices market revenue share
End-user segments the market into hospitals & clinics, laboratories, and home care. The segment of hospitals and clinics held the largest share of the market.
Because more patients are choosing to visit hospitals and clinics to check for illnesses and the RSV virus. Additionally, growing demand for RSV detection among newborns and the geriatric population, as well as increased usage of point of care (POC) molecular diagnostic instruments in hospitals & clinics in developing countries, have fuelled the segment's market expansion. While the homecare category is anticipated to expand at the quickest, rate over the projection period since it offers more affordable care than hospitalization and has access to experts with the necessary training.
RSV Diagnostics Market Share (%) by End User in 2019-2031
2019
2023
2031
The above Graph is for representation purposes only. This chart does not depict actual Market share. Please purchase the RSV Diagnostics market report 2024 Edition by contacting our team.
RSV Diagnostics Method Segment Analysis
- Immunoassays
- Molecular Diagnostics
- Flow Cytometry
- Rapid Antigen Detection Tests
- Chromatography
Author's Detail
Anushka GoreResearch Associate at Cognitive Market Research
Anushka Gore is a seasoned market researcher specializing in the dynamic landscape of the Pharmaceutical industry. With a keen analytical mind and a deep passion for healthcare advancements, she has dedicated herself unraveling the intricate market trends and consumer behaviors that shape the future of medical technologies and services.
Anushka is a highly motivated and detail-oriented research analyst with a passion for uncovering valuable insights from data. Her expertise in Market Research and business intelligence has equipped her with the skills necessary to analyze complex information and provide strategic recommendations. She thrives in dynamic environments where her analytical abilities and research expertise can contribute to informed decision-making for businesses
I played a pivotal role in conducting market research and competitive analysis. I have a demonstrated ability to synthesize diverse data sources, identify trends, and translate findings into actionable recommendations. My collaborative approach facilitated effective communication of insights, fostering a data-driven culture within the organization. I am committed to maintaining excellence through continuous learning and staying ahead of industry trends. Regular participation in conferences and professional development opportunities keeps my skills sharp and relevant.
Author's Conclusion
Our study will explain complete manufacturing process along with major raw materials required to manufacture end-product. This report helps to make effective decisions determining product position and will assist you to understand opportunities and threats around the globe.
The Global RSV Diagnostics Market is witnessing significant growth in the near future.
In 2023, the Instruments segment accounted for noticeable share of global RSV Diagnostics Market and is projected to experience significant growth in the near future.
The Hospitals and Clinics segment is expected to expand at the significant CAGR retaining position throughout the forecast period.
Some of the key companies Abbott , Becton and others are focusing on its strategy building model to strengthen its product portfolio and expand its business in the global market.
Frequently Asked Questions
Latest News about RSV Diagnostics Market
Sources from Medical Devices & Consumables Industry
- http://www.trade.gov
- http://www.gov.uk
- http://www.fda.gov
- http://www.hhs.gov
- http://www.who.int
- http://www.bls.gov
- http://www.gao.gov
- http://www.ncbi.nlm.nih.gov
- http://www.healthcaredive.com
- http://www.weforum.org
- http://www.health.gov.za
- http://www.usaid.gov
- http://www.eumdr.com
- http://www.cdc.gov
- http://www.ama-assn.org
- http://www.washingtonpost.com
- http://www.ecfr.gov
- http://www.hbr.org
- http://www.worldbank.org
- http://www.commission.europa.eu
- http://www.cbi.eu
- http://www.unicef.org
- http://www.ecipe.org
- http://www.ema.europa.eu
RSV Diagnostics Market Report Table of Content
Disclaimer:
- This is just a redacted sample pages of the actual deliverable report and only for representative purposes
- Charts/Graphs/Numbers/data are only for Representative purposes and do not depict actual statistics.
- The table of Contents differs according to the user License selection. Current Displayed TOC is for the Corporate User License Report Edition. TOC Customization options: Add or Remove section/s Or chapter/s from the report.
- Specific Tables, Graphs, Sections, and Chapters can be ordered at a discounted price.
- If applicable; On Request Volume Data will also be provided (at an Additional Cost).
| Product | Instruments, Kits and Reagents, Others |
| End User | Hospitals and Clinics, Clinical Laboratories, Homecare, Others |
| Method | Immunoassays, Molecular Diagnostics, Flow Cytometry, Rapid Antigen Detection Tests, Chromatography |
| List of Competitors | Abbott, BIOMERIEUX (France), Becton, Dickinson and Company, Merck KGaA, DiaSorin Molecular LLC, F. Hoffman La. Roche Ltd, Danaher, bioMérieux SA, Thermo Fisher Scientific Inc., Luminex Corporation, Quest Diagnostics Incorporated, BioCartis, Hologic, Inc., Fast Track Diagnostics Luxembourg S.à r.l., Beckman Coulter Inc., Ortho-Clinical Diagnostics, Bio-Rad Laboratories Inc. Quidel Corporation, DiaSorin S.p.A. |
This chapter will help you gain GLOBAL Market Analysis of RSV Diagnostics. Further deep in this chapter, you will be able to review Global RSV Diagnostics Market Split by various segments and Geographical Split.
Chapter 1 Global Market Analysis
-
1.1 Global RSV Diagnostics Market Size, Trend Analysis 2019 - 2031
-
1.2 Global RSV Diagnostics Market Size By Regions 2019 - 2031
Global Market has been segmented on the basis 5 major regions such as North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America.
-
1.2.1 Global RSV Diagnostics Revenue Market Size By Region
-
-
1.3 Global RSV Diagnostics Market Size By Product 2019 -2031
-
1.3.1 Instruments Market Size
-
1.3.2 Kits and Reagents Market Size
-
1.3.3 Others Market Size
-
-
1.4 Global RSV Diagnostics Market Size By End User 2019 -2031
-
1.4.1 Hospitals and Clinics Market Size
-
1.4.2 Clinical Laboratories Market Size
-
1.4.3 Homecare Market Size
-
1.4.4 Others Market Size
-
-
1.5 Global RSV Diagnostics Market Size By Method 2019 -2031
-
1.5.1 Immunoassays Market Size
-
1.5.2 Molecular Diagnostics Market Size
-
1.5.3 Flow Cytometry Market Size
-
1.5.4 Rapid Antigen Detection Tests Market Size
-
1.5.5 Chromatography Market Size
-
-
1.6 Global Level Competitor Analysis (Subject to Data Availability (Private Players))
-
1.7 Executive Summary Global Market (2019 vs 2024 vs 2031)
You can purchase only the Executive Summary of Global Market (2019 vs 2024 vs 2031)
-
1.7.1 Regional Market Revenue Summary 2019 vs 2024 vs 2031
-
1.7.2 Global Market Revenue Split By Product
-
1.7.3 Global Market Revenue Split By End User
-
1.7.4 Global Market Revenue Split By Method
-
1.7.5 Global Market Dynamics, Trends, Drivers, Restraints, Opportunities
Global Market Dynamics, Trends, Drivers, Restraints, Opportunities, Only Pointers will be deliverable
-
Chapter 2 North America Market Analysis
-
2.1 North America RSV Diagnostics Market Size 2019 - 2031
-
2.1.1 North America RSV Diagnostics Market Size By Country 2019 - 2031
-
2.1.2 North America RSV Diagnostics Market Size by Product 2019 -2031
-
2.1.2.1 North America Instruments Market Size
-
2.1.2.2 North America Kits and Reagents Market Size
-
2.1.2.3 North America Others Market Size
-
-
2.1.3 North America RSV Diagnostics Market Size by End User 2019 -2031
-
2.1.3.1 North America Hospitals and Clinics Market Size
-
2.1.3.2 North America Clinical Laboratories Market Size
-
2.1.3.3 North America Homecare Market Size
-
2.1.3.4 North America Others Market Size
-
-
2.1.4 North America RSV Diagnostics Market Size by Method 2019 -2031
-
2.1.4.1 North America Immunoassays Market Size
-
2.1.4.2 North America Molecular Diagnostics Market Size
-
2.1.4.3 North America Flow Cytometry Market Size
-
2.1.4.4 North America Rapid Antigen Detection Tests Market Size
-
2.1.4.5 North America Chromatography Market Size
-
-
-
2.2 Add-Ons: Customize the Report Edition
Purchase Add-Ons to Customize the Report Edition and get further granular data level data about the North America market. Add-On Cost: Request before placing the order, Respective Pricing will be informed after sending the inquiry
-
2.2.1 North America Company Market Share 2019 till 2023
-
2.2.2 Qualitative Analysis for North America Market
Qualitative Analysis for the North America Market: North America RSV Diagnostics Market Trends North America RSV Diagnostics Technological Road Map North America RSV Diagnostics Market Drivers North America RSV Diagnostics Market Restraints North America RSV Diagnostics Market Opportunity Market Attractiveness Analysis COVID – 19 Impact Analysis PESTEL Analysis Porter’s Five Forces Analysis Product Life Cycle Industrial Chain Analysis
-
-
2.3 Executive Summary North America Market (2019 vs 2024 vs 2031)
You can purchase only the Executive Summary North America Market (2019 vs 2024 vs 2031)
-
2.3.1 North America Market Summary 2019 vs 2024 vs 2031
-
2.3.2 North America Market Revenue Split By Product
-
2.3.3 North America Market Revenue Split By End User
-
2.3.4 North America Market Revenue Split By Method
-
Chapter 3 Europe Market Analysis
-
3.1 Europe RSV Diagnostics Market Size 2019 - 2031
-
3.1.1 Europe RSV Diagnostics Market Size By Country 2019 - 2031
-
3.1.2 Europe RSV Diagnostics Market Size by Product 2019 -2031
-
3.1.2.1 Europe Instruments Market Size
-
3.1.2.2 Europe Kits and Reagents Market Size
-
3.1.2.3 Europe Others Market Size
-
-
3.1.3 Europe RSV Diagnostics Market Size by End User 2019 -2031
-
3.1.3.1 Europe Hospitals and Clinics Market Size
-
3.1.3.2 Europe Clinical Laboratories Market Size
-
3.1.3.3 Europe Homecare Market Size
-
3.1.3.4 Europe Others Market Size
-
-
3.1.4 Europe RSV Diagnostics Market Size by Method 2019 -2031
-
3.1.4.1 Europe Immunoassays Market Size
-
3.1.4.2 Europe Molecular Diagnostics Market Size
-
3.1.4.3 Europe Flow Cytometry Market Size
-
3.1.4.4 Europe Rapid Antigen Detection Tests Market Size
-
3.1.4.5 Europe Chromatography Market Size
-
-
-
3.2 Add-Ons: Customize the Report Edition
-
3.2.1 Europe Company Market Share 2019 till 2023
-
3.2.2 Qualitative Analysis for Europe Market
-
-
3.3 Executive Summary Europe Market (2019 vs 2024 vs 2031)
You can purchase only the Executive Summary Europe Market (2019 vs 2024 vs 2031)
-
3.3.1 Europe Revenue Market Summary 2019 vs 2024 vs 2031
-
3.3.2 Europe Market Revenue Split By Product
-
3.3.3 Europe Market Revenue Split By End User
-
3.3.4 Europe Market Revenue Split By Method
-
Chapter 4 Asia-Pacific Market Analysis
-
4.1 Asia Pacific RSV Diagnostics Market Size 2019 - 2031
-
4.1.1 Asia Pacific RSV Diagnostics Market Size By Country 2019 - 2031
-
4.1.2 Asia Pacific RSV Diagnostics Market Size by Product 2019 -2031
-
4.1.2.1 Asia Pacific Instruments Market Size
-
4.1.2.2 Asia Pacific Kits and Reagents Market Size
-
4.1.2.3 Asia Pacific Others Market Size
-
-
4.1.3 Asia Pacific RSV Diagnostics Market Size by End User 2019 -2031
-
4.1.3.1 Asia Pacific Hospitals and Clinics Market Size
-
4.1.3.2 Asia Pacific Clinical Laboratories Market Size
-
4.1.3.3 Asia Pacific Homecare Market Size
-
4.1.3.4 Asia Pacific Others Market Size
-
-
4.1.4 Asia Pacific RSV Diagnostics Market Size by Method 2019 -2031
-
4.1.4.1 Asia Pacific Immunoassays Market Size
-
4.1.4.2 Asia Pacific Molecular Diagnostics Market Size
-
4.1.4.3 Asia Pacific Flow Cytometry Market Size
-
4.1.4.4 Asia Pacific Rapid Antigen Detection Tests Market Size
-
4.1.4.5 Asia Pacific Chromatography Market Size
-
-
-
4.2 Add-Ons: Customize the Report Edition
-
4.2.1 Asia Pacific Company Market Share 2019 till 2023
-
4.2.2 Qualitative Analysis for Asia Pacific Market
-
-
4.3 Executive Summary Asia Pacific Market (2019 vs 2024 vs 2031)
You can purchase only the Executive Summary Asia Pacific Market (2019 vs 2024 vs 2031)
-
4.3.1 Asia Pacific Market Summary 2019 vs 2024 vs 2031
-
4.3.2 Asia Pacific Market Revenue Split By Product
-
4.3.3 Asia Pacific Market Revenue Split By End User
-
4.3.4 Asia Pacific Market Revenue Split By Method
-
Chapter 5 South America Market Analysis
-
5.1 South America RSV Diagnostics Market Size 2019 - 2031
-
5.1.1 South America RSV Diagnostics Revenue Market Size By Country 2019 - 2031
-
5.1.2 South America RSV Diagnostics Market Size by Product 2019 -2031
-
5.1.2.1 South America Instruments Market Size
-
5.1.2.2 South America Kits and Reagents Market Size
-
5.1.2.3 South America Others Market Size
-
-
5.1.3 South America RSV Diagnostics Market Size by End User 2019 -2031
-
5.1.3.1 South America Hospitals and Clinics Market Size
-
5.1.3.2 South America Clinical Laboratories Market Size
-
5.1.3.3 South America Homecare Market Size
-
5.1.3.4 South America Others Market Size
-
-
5.1.4 South America RSV Diagnostics Market Size by Method 2019 -2031
-
5.1.4.1 South America Immunoassays Market Size
-
5.1.4.2 South America Molecular Diagnostics Market Size
-
5.1.4.3 South America Flow Cytometry Market Size
-
5.1.4.4 South America Rapid Antigen Detection Tests Market Size
-
5.1.4.5 South America Chromatography Market Size
-
-
-
5.2 Add-Ons: Customize the Report Edition
-
5.2.1 South America Company Market Share 2019 till 2023
-
5.2.2 Qualitative Analysis for South America Market
-
-
5.3 Executive Summary South America Market (2019 vs 2024 vs 2031)
You can purchase only the Executive Summary South America Market (2019 vs 2024 vs 2031)
-
5.3.1 South America Market Summary 2019 vs 2024 vs 2031
-
5.3.2 South America Market Revenue Split By Product
-
5.3.3 South America Market Revenue Split By End User
-
5.3.4 South America Market Revenue Split By Method
-
Chapter 6 Middle East and Africa Market Analysis
-
6.1 Middle East and Africa RSV Diagnostics Market Size 2019 - 2031
-
6.1.1 Middle East and Africa RSV Diagnostics Revenue Market Size By Country 2019 - 2031
-
6.1.2 Middle East and Africa RSV Diagnostics Market Size by Product 2019 -2031
-
6.1.2.1 Middle East and Africa Instruments Market Size
-
6.1.2.2 Middle East and Africa Kits and Reagents Market Size
-
6.1.2.3 Middle East and Africa Others Market Size
-
-
6.1.3 Middle East and Africa RSV Diagnostics Market Size by End User 2019 -2031
-
6.1.3.1 Middle East and Africa Hospitals and Clinics Market Size
-
6.1.3.2 Middle East and Africa Clinical Laboratories Market Size
-
6.1.3.3 Middle East and Africa Homecare Market Size
-
6.1.3.4 Middle East and Africa Others Market Size
-
-
6.1.4 Middle East and Africa RSV Diagnostics Market Size by Method 2019 -2031
-
6.1.4.1 Middle East and Africa Immunoassays Market Size
-
6.1.4.2 Middle East and Africa Molecular Diagnostics Market Size
-
6.1.4.3 Middle East and Africa Flow Cytometry Market Size
-
6.1.4.4 Middle East and Africa Rapid Antigen Detection Tests Market Size
-
6.1.4.5 Middle East and Africa Chromatography Market Size
-
-
-
6.2 Add-Ons: Customize the Report Edition
-
6.2.1 Middle East and Africa Company Market Share 2019 till 2023
-
6.2.2 Qualitative Analysis for Middle East and Africa Market
-
-
6.3 Executive Summary Middle East and Africa Market (2019 vs 2024 vs 2031)
You can purchase only the Executive Summary Middle East and Africa Market (2019 vs 2024 vs 2031)
-
6.3.1 Middle East and Africa Market Summary 2019 vs 2024 vs 2031
-
6.3.2 Middle East and Africa Market Revenue Split By Product
-
6.3.3 Middle East and Africa Market Revenue Split By End User
-
6.3.4 Middle East and Africa Market Revenue Split By Method
-
Only Available with Corporate User License
Chapter 7 Top 10 Countries Analysis
-
7.1 Country 1 Market Analysis
-
7.1.1 Country 1RSV Diagnostics Market Size by Product 2019 -2031
-
7.1.2 Country 1RSV Diagnostics Market Size by End User 2019 -2031
-
7.1.3 Country 1RSV Diagnostics Market Size by Method 2019 -2031
-
-
7.2 Country 2 Market Analysis
-
7.2.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.3 Country 3 Market Analysis
-
7.3.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.4 Country 4 Market Analysis
-
7.4.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.5 Country 5 Market Analysis
-
7.5.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.6 Country 6 Market Analysis
-
7.6.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.7 Country 7 Market Analysis
-
7.7.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.8 Country 8 Market Analysis
-
7.8.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.9 Country 9 Market Analysis
-
7.9.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.10 Country 10 Market Analysis
-
7.10.1 Segmentation Analysis will be provided as shown for Country 1
-
Competitor's Market Share and Revenue (Subject to Data Availability for Private Players)
Chapter 8 Competitor Analysis (Subject to Data Availability (Private Players))
-
8.1 Top Competitors Analysis
-
8.1.1 Top Players Ranking 2022
-
8.1.2 Global RSV Diagnostics Market Revenue and Share by Manufacturers (2019-2023)
(Subject to Data Availability (Private Players))
-
8.1.3 Industry Mergers and Acquisition Analysis
-
8.1.4 New Product Launch Analysis
-
-
8.2 Company Profile (Data Subject to Availability)
-
8.2.1 Abbott
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.1.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.1.2 Business Overview
-
8.2.1.3 Financials (Subject to data availability)
-
8.2.1.4 Product Types Specification
-
8.2.1.5 Business Strategy
-
8.2.1.6 S.W.O.TAnalysis
-
-
8.2.2 BIOMERIEUX (France)
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.2.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.2.2 Business Overview
-
8.2.2.3 Financials (Subject to data availability)
-
8.2.2.4 Product Types Specification
-
8.2.2.5 Business Strategy
-
8.2.2.6 S.W.O.TAnalysis
-
-
8.2.3 Becton
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.3.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.3.2 Business Overview
-
8.2.3.3 Financials (Subject to data availability)
-
8.2.3.4 Product Types Specification
-
8.2.3.5 Business Strategy
-
8.2.3.6 S.W.O.TAnalysis
-
-
8.2.4 Dickinson and Company
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.4.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.4.2 Business Overview
-
8.2.4.3 Financials (Subject to data availability)
-
8.2.4.4 Product Types Specification
-
8.2.4.5 Business Strategy
-
8.2.4.6 S.W.O.TAnalysis
-
-
8.2.5 Merck KGaA
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.5.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.5.2 Business Overview
-
8.2.5.3 Financials (Subject to data availability)
-
8.2.5.4 Product Types Specification
-
8.2.5.5 Business Strategy
-
8.2.5.6 S.W.O.TAnalysis
-
-
8.2.6 DiaSorin Molecular LLC
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.6.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.6.2 Business Overview
-
8.2.6.3 Financials (Subject to data availability)
-
8.2.6.4 Product Types Specification
-
8.2.6.5 Business Strategy
-
8.2.6.6 S.W.O.TAnalysis
-
-
8.2.7 F. Hoffman La. Roche Ltd
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.7.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.7.2 Business Overview
-
8.2.7.3 Financials (Subject to data availability)
-
8.2.7.4 Product Types Specification
-
8.2.7.5 Business Strategy
-
8.2.7.6 S.W.O.TAnalysis
-
-
8.2.8 Danaher
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.8.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.8.2 Business Overview
-
8.2.8.3 Financials (Subject to data availability)
-
8.2.8.4 Product Types Specification
-
8.2.8.5 Business Strategy
-
8.2.8.6 S.W.O.TAnalysis
-
-
8.2.9 bioMérieux SA
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.9.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.9.2 Business Overview
-
8.2.9.3 Financials (Subject to data availability)
-
8.2.9.4 Product Types Specification
-
8.2.9.5 Business Strategy
-
8.2.9.6 S.W.O.TAnalysis
-
-
8.2.10 Thermo Fisher Scientific Inc.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.10.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.10.2 Business Overview
-
8.2.10.3 Financials (Subject to data availability)
-
8.2.10.4 Product Types Specification
-
8.2.10.5 Business Strategy
-
8.2.10.6 S.W.O.TAnalysis
-
-
8.2.11 Luminex Corporation
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.11.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.11.2 Business Overview
-
8.2.11.3 Financials (Subject to data availability)
-
8.2.11.4 Product Types Specification
-
8.2.11.5 Business Strategy
-
8.2.11.6 S.W.O.TAnalysis
-
-
8.2.12 Quest Diagnostics Incorporated
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.12.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.12.2 Business Overview
-
8.2.12.3 Financials (Subject to data availability)
-
8.2.12.4 Product Types Specification
-
8.2.12.5 Business Strategy
-
8.2.12.6 S.W.O.TAnalysis
-
-
8.2.13 BioCartis
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.13.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.13.2 Business Overview
-
8.2.13.3 Financials (Subject to data availability)
-
8.2.13.4 Product Types Specification
-
8.2.13.5 Business Strategy
-
8.2.13.6 S.W.O.TAnalysis
-
-
8.2.14 Hologic
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.14.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.14.2 Business Overview
-
8.2.14.3 Financials (Subject to data availability)
-
8.2.14.4 Product Types Specification
-
8.2.14.5 Business Strategy
-
8.2.14.6 S.W.O.TAnalysis
-
-
8.2.15 Inc.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.15.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.15.2 Business Overview
-
8.2.15.3 Financials (Subject to data availability)
-
8.2.15.4 Product Types Specification
-
8.2.15.5 Business Strategy
-
8.2.15.6 S.W.O.TAnalysis
-
-
8.2.16 Fast Track Diagnostics Luxembourg S.à r.l.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.16.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.16.2 Business Overview
-
8.2.16.3 Financials (Subject to data availability)
-
8.2.16.4 Product Types Specification
-
8.2.16.5 Business Strategy
-
8.2.16.6 S.W.O.TAnalysis
-
-
8.2.17 Beckman Coulter Inc.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.17.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.17.2 Business Overview
-
8.2.17.3 Financials (Subject to data availability)
-
8.2.17.4 Product Types Specification
-
8.2.17.5 Business Strategy
-
8.2.17.6 S.W.O.TAnalysis
-
-
8.2.18 Ortho-Clinical Diagnostics
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.18.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.18.2 Business Overview
-
8.2.18.3 Financials (Subject to data availability)
-
8.2.18.4 Product Types Specification
-
8.2.18.5 Business Strategy
-
8.2.18.6 S.W.O.TAnalysis
-
-
8.2.19 Bio-Rad Laboratories Inc. Quidel Corporation
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.19.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.19.2 Business Overview
-
8.2.19.3 Financials (Subject to data availability)
-
8.2.19.4 Product Types Specification
-
8.2.19.5 Business Strategy
-
8.2.19.6 S.W.O.TAnalysis
-
-
8.2.20 DiaSorin S.p.A.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.20.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.20.2 Business Overview
-
8.2.20.3 Financials (Subject to data availability)
-
8.2.20.4 Product Types Specification
-
8.2.20.5 Business Strategy
-
8.2.20.6 S.W.O.TAnalysis
-
-
Chapter 9 Qualitative Analysis (Subject to Data Availability)
-
9.1 Market Drivers
-
9.2 Market Trends
-
9.3 Market Restraints
-
9.4 Market Opportunity
-
9.5 Product Life Cycle (Subject to Data Availability)
-
9.6 Industrial Chain Analysis (Subject to Data Availability)
-
9.6.1 Industry Chain Analysis
-
9.6.2 Manufacturing Cost Analysis
-
9.6.3 Consumer Preference Analysis
-
9.6.4 Supply Side Analysis
-
9.6.4.1 Raw Material Analysis
-
9.6.4.2 Raw Material Procurement Analysis
-
9.6.4.3 Raw Material Price Trend Analysis
-
-
-
9.7 Market Attractiveness Analysis
-
9.8 PESTEL Analysis
-
9.9 Porter’s Five Forces Analysis
-
9.10 Patent Analysis (Subject to Data Availability)
-
9.11 ESG Analysis
-
9.12 Technological Road Map
Segmentation Product Analysis 2019 -2031, will provide market size split by Product. This Information is provided at Global Level, Regional Level and Top Countries Level The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 10 Market Split by Product Analysis 2019 -2031
-
10.1 Instruments
-
10.1.1 Global RSV Diagnostics Revenue Market Size and Share by Instruments 2019 -2031
-
-
10.2 Kits and Reagents
-
10.2.1 Global RSV Diagnostics Revenue Market Size and Share by Kits and Reagents 2019 -2031
-
-
10.3 Others
-
10.3.1 Global RSV Diagnostics Revenue Market Size and Share by Others 2019 -2031
-
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 11 Market Split by End User Analysis 2019 -2031
-
11.1 Hospitals and Clinics
-
11.1.1 Global RSV Diagnostics Revenue Market Size and Share by Hospitals and Clinics 2019 - 2031
-
-
11.2 Clinical Laboratories
-
11.2.1 Global RSV Diagnostics Revenue Market Size and Share by Clinical Laboratories 2019 - 2031
-
-
11.3 Homecare
-
11.3.1 Global RSV Diagnostics Revenue Market Size and Share by Homecare 2019 - 2031
-
-
11.4 Others
-
11.4.1 Global RSV Diagnostics Revenue Market Size and Share by Others 2019 - 2031
-
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 12 Market Split by Method Analysis 2019 -2031
-
12.1 Immunoassays
-
12.1.1 Global RSV Diagnostics Revenue Market Size and Share by Immunoassays 2019 -2031
-
-
12.2 Molecular Diagnostics
-
12.2.1 Global RSV Diagnostics Revenue Market Size and Share by Molecular Diagnostics 2019 -2031
-
-
12.3 Flow Cytometry
-
12.3.1 Global RSV Diagnostics Revenue Market Size and Share by Flow Cytometry 2019 -2031
-
-
12.4 Rapid Antigen Detection Tests
-
12.4.1 Global RSV Diagnostics Revenue Market Size and Share by Rapid Antigen Detection Tests 2019 -2031
-
-
12.5 Chromatography
-
12.5.1 Global RSV Diagnostics Revenue Market Size and Share by Chromatography 2019 -2031
-
This chapter helps you understand the Key Takeaways and Analyst Point of View of the global RSV Diagnostics market
Chapter 13 Research Findings
-
13.1 Key Takeaways
-
13.2 Analyst Point of View
Here the analyst will summarize the content of entire report and will share his view point on the current industry scenario and how the market is expected to perform in the near future. The points shared by the analyst are based on his/her detailed in-depth understanding of the market during the course of this report study. You will be provided exclusive rights to interact with the concerned analyst for unlimited time pre purchase as well as post purchase of the report.
-
13.3 Assumptions and Acronyms
Sample Format of Deliverables
The Tables, Graphs/Charts are only for representative purposes and do not depict actual statistics. Purchase full Report access to actual data.
Qualitative Analysis
Research Methodology Implemented by Anushka Gore and Team
- 1.1 RSV Diagnostics Market Report 2024 Research Methodology
- 1.2 Systematic Research Approach
- 1.2.1 Primary Research for RSV Diagnostics Market
- 1.2.1.1 Key Data from Primary
- 1.2.1.2 Primary Interviews with Experts
- 1.2.1.3 Key Industry Insights
- 1.2.1.4 Questionnaire for RSV Diagnostics Market
- 1.2.1.5 Breakdown of Primaries
- 1.2.2 Secondary Research for RSV Diagnostics Market
- 1.2.2.1 Key Data from Secondary
- 1.2.2.2 Paid Sources
- 1.2.2.3 Public Sources
- 1.3 Market Size Estimation for RSV Diagnostics Market
- 1.3.1 Top-Down Approach
- 1.3.1.1 Analyzing Market Size by Top-Down Approach (Supply Side)
- 1.3.2 Bottom-UP Approach
- 1.3.2.1 Analyzing Market Size by Bottom-Up Approach (Demand Side)
- 1.3.1 Top-Down Approach
- 1.4 Market Breakdown and Data Triangulation
- 1.5 Research Assumptions for RSV Diagnostics Market
Key Questions Answered By RSV Diagnostics Market Report 2024
| Why Instruments have a significant impact on RSV Diagnostics market? |
| What are the key factors affecting the Instruments and Kits and Reagents of RSV Diagnostics Market? |
| What is the CAGR/Growth Rate of Hospitals and Clinics during the forecast period? |
| By type, which segment accounted for largest share of the global RSV Diagnostics Market? |
| Which region is expected to dominate the global RSV Diagnostics Market within the forecast period? |
| Segmentation Level Customization |
|
| Global level Data Customization |
|
| Region level Data Customization |
|
| Country level Data Customization |
|
| Company Level |
|
| Additional Data Analysis |
|
| Additional Qualitative Data |
|
| Additional Quantitative Data |
|
| Service Level Customization |
|
Report Format Alteration |
|
